MX2015015742A - Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity. - Google Patents

Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity.

Info

Publication number
MX2015015742A
MX2015015742A MX2015015742A MX2015015742A MX2015015742A MX 2015015742 A MX2015015742 A MX 2015015742A MX 2015015742 A MX2015015742 A MX 2015015742A MX 2015015742 A MX2015015742 A MX 2015015742A MX 2015015742 A MX2015015742 A MX 2015015742A
Authority
MX
Mexico
Prior art keywords
overweight
venous
obesity
treatment
lymphatic system
Prior art date
Application number
MX2015015742A
Other languages
Spanish (es)
Inventor
Rodriguez Graciela Figueiredo
Original Assignee
Rodriguez Graciela Figueiredo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rodriguez Graciela Figueiredo filed Critical Rodriguez Graciela Figueiredo
Publication of MX2015015742A publication Critical patent/MX2015015742A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a pharmaceutical formula for the treatment of diseases which affect the venous and lymphatic system, overweight and obesity which comprises, at least, phlebotonic, lymphokinetic, proteolytic and lipolytic substances, arterial circulation stimulants, vitamins, minerals, anti-inflammatories, bactericides, immunostimulants and hepatic function regulators.
MX2015015742A 2013-05-14 2013-05-14 Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity. MX2015015742A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2013/070305 WO2014184398A1 (en) 2013-05-14 2013-05-14 Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity

Publications (1)

Publication Number Publication Date
MX2015015742A true MX2015015742A (en) 2016-05-16

Family

ID=51897794

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015742A MX2015015742A (en) 2013-05-14 2013-05-14 Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity.

Country Status (2)

Country Link
MX (1) MX2015015742A (en)
WO (1) WO2014184398A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107788177A (en) * 2017-11-27 2018-03-13 爱可道生物科技有限公司 A kind of globe artichoke compound health instant tea

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Also Published As

Publication number Publication date
WO2014184398A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
CY1124407T1 (en) AUTOTAXIN INHIBITOR COMPOUNDS
HRP20190117T1 (en) Mrna therapy for the treatment of ocular diseases
HK1247922A1 (en) Inhibitors of indoleamine 2,3-dioxygenase for the treatment of cancer
CY1120452T1 (en) PYRAZOLIS AMIDE PRODUCT
PH12016502256A1 (en) Medical use
BR112017015059A2 (en) proteasome inhibitor and use
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
EA201691624A1 (en) Heterocyclic Compound
MA42657A (en) ANTI-PCSK9 ANTIBODY INHIBITORS FOR THE TREATMENT OF PATIENTS WITH HYPERLIPIDEMIA SUBJECTING LIPOPROTEIN APHERESIS
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
EA201892265A1 (en) METHODS OF TREATMENT OF OPHTHALMIC DISEASES
TN2015000558A1 (en) Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (ic/bps)
MA53568A (en) DRUGS FOR THE TREATMENT OF OPHTHALMIC DISEASES
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
BR112016024488A2 (en) cyclohexenyl compounds, compositions comprising them and the use thereof
CY1122374T1 (en) BIOTIN FOR THE THERAPEUTIC TREATMENT OF DEMYELINOTIC NEUROPATHIES
BR112015024703A2 (en) pharmaceutical formulation, method of treatment and / or prevention of restenosis and kit for the treatment and / or prevention of restenosis
IL261116A (en) Medicament for treatment of diabetic foot infections
MX2015015742A (en) Pharmaceutical formula for the treatment of diseases affecting the venous and lymphatic system, overweight and obesity.
CL2015003679A1 (en) Therapeutic agents for use in the prophylaxis and / or treatment of hyperkinetic movement disorders
BR112018005305A2 (en) Prevention or the medical treatment agent of a cornea mycosis
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
DOP2015000290A (en) BENZOXAZOLES REPLACED